Cargando…
The Treatment of Multiple Myeloma Patients Not Eligible for Asct
Advances in therapies for younger patients with multiple myeloma have resulted in significant improvements in outcome over recent years, on the contrary the progress in treatments for elderly patients has remained more modest. Traditionally, patients who are not eligible for transplantation, like th...
Autores principales: | Richardson, Paul, Laubach, Jacob, Mahindra, Anuj, Mitsiades, Constantine, Schlossman, Robert, Ghobrial, Irene, Hideshima, Teru, Raje, Noopur, Munshi, Nikhil, Anderson., Kenneth |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033138/ https://www.ncbi.nlm.nih.gov/pubmed/21415962 http://dx.doi.org/10.4084/MJHID.2010.009 |
Ejemplares similares
-
Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy
por: Richardson, Paul, et al.
Publicado: (2010) -
The Medical Research Council Myeloma IX trial: the impact on treatment paradigms*
por: Richardson, Paul G, et al.
Publicado: (2012) -
Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009) -
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma
por: Hideshima, Teru, et al.
Publicado: (2008) -
Lenalidomide for the treatment of relapsed and refractory multiple myeloma
por: van de Donk, Niels WCJ, et al.
Publicado: (2012)